Reirradiation Options for Previously Irradiated Prostate Cancer: Is It Feasible to Randomise Between Treatment With Stereotactic Body Radiotherapy (SBRT) Versus High-Dose-Rate Brachytherapy?
Open Access
- 19 February 2026
- journal article
- research article
- Published by Elsevier in Clinical Oncology
- Vol. 52, 104085
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical ProstatectomyJAMA Network Open, 2023
- The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 StudyEuropean Urology Oncology, 2023
- Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)European Urology, 2022
- A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER)European Urology, 2021
- Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensusCancer Treatment Reviews, 2021
- Single-Dose Focal Salvage High Dose Rate Brachytherapy for Locally Recurrent Prostate CancerClinical Oncology, 2020
- Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized TrialsEuropean Urology, 2020
- Recent Global Patterns in Prostate Cancer Incidence and Mortality RatesEuropean Urology, 2020
- Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewEuropean Urology, 2019
- A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapyBrachytherapy, 2014